22 insiders reported 261 Form 4 transactions for Lionsgate Studios Corp. (LION) over the past 18 months (most recent 2026-09-17). Recent activity: RACHESKY MARK H MD (Director) Buy 6,792 shares, Ostolaza Yvette (Director) Buy 5,362 shares, SLOAN HARRY (Director) Buy 13,405 shares, Rosenblatt M Richard (Director) Buy 13,405 shares, Crawford Gordon (Director) Buy 13,405 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | RACHESKY MARK H MD | Director | Buy | 6,792 | $76,002 |
| 2026-09-17 | Ostolaza Yvette | Director | Buy | 5,362 | $60,001 |
| 2026-09-17 | SLOAN HARRY | Director | Buy | 13,405 | $0 |
| 2026-09-17 | Rosenblatt M Richard | Director | Buy | 13,405 | $0 |
| 2026-09-17 | Crawford Gordon | Director | Buy | 13,405 | $0 |
| 2026-09-17 | FINE EMILY | Director | Buy | 4,468 | $49,997 |
| 2026-09-17 | McCaw Susan | Director | Buy | 13,405 | $0 |
| 2026-09-17 | HARKEY JOHN D JR | Director | Buy | 13,405 | $0 |
| 2026-09-17 | RACHESKY MARK H MD | Director | Buy | 13,405 | $150,002 |
| 2026-09-17 | HARKEY JOHN D JR | Director | Buy | 5,809 | $65,003 |
| 2026-09-17 | SLOAN HARRY | Director | Buy | 5,362 | $60,001 |
| 2026-09-17 | Rosenblatt M Richard | Director | Buy | 4,468 | $49,997 |
| 2026-09-17 | Crawford Gordon | Director | Buy | 4,468 | $49,997 |
| 2026-09-17 | FINE EMILY | Director | Buy | 13,405 | $150,002 |
| 2026-09-17 | Ostolaza Yvette | Director | Buy | 13,405 | $0 |
| 2026-07-10 | RACHESKY MARK H MD | Director | Sell | 1.5M | $0 |
| 2026-07-10 | FELTHEIMER JON | Chief Executive Officer | Sell | 103,669 | $1.5M |
| 2026-07-10 | RACHESKY MARK H MD | Director | Sell | 3.7M | $0 |
| 2026-07-10 | FELTHEIMER JON | Chief Executive Officer | Buy | 196,902 | $0 |
| 2026-07-10 | RACHESKY MARK H MD | Director | Buy | 671,924 | $0 |
| 2026-07-10 | FELTHEIMER JON | Chief Executive Officer | Sell | 103,669 | $1.5M |
| 2026-07-10 | RACHESKY MARK H MD | Director | Buy | 797,526 | $0 |
| 2026-07-10 | RACHESKY MARK H MD | Director | Buy | 1.9M | $0 |
| 2026-07-10 | RACHESKY MARK H MD | Director | Buy | 11.2M | $0 |
| 2026-07-10 | RACHESKY MARK H MD | Director | Sell | 25.2M | $0 |
Source: SEC Form 4 filings · as of 2026-09-17